Search

everythinglearnresearchcommunity

for

Search:↓

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Testosterone may influence COVID-19 severity and outcomes.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Frankincense may help treat COVID-19, but more research is needed.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Innovative biomaterials show promise in healing chronic diabetic foot ulcers.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Psychiatrists are crucial in pain management teams because they help treat severe pain and related mental health issues.